<DOC>
	<DOCNO>NCT02407197</DOCNO>
	<brief_summary>Myocardial fibrosis fundamental substrate development heart failure . Cardiovascular magnetic resonance ( CMR ) allow non-invasive assessment myocardial fibrosis base late gadolinium enhancement ( LGE ) T1 mapping . Patients : Prospective longitudinal observational multicenter study consecutive patient suspect known non-ischemic cardiomyopathy . Imaging : Non-invasive measure myocardial fibrosis : native T1 , extracellular volume fraction ( ECV ) LGE . Primary endpoint : cause cardiovascular mortality . Secondary endpoint : arrhythmic composite HF composite endpoint .</brief_summary>
	<brief_title>International T1 Multicentre CMR Outcome Study Patients With Nonischaemic Cardiomyopathies</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Patients fulfil criterion NICM OR presence structural heart disease OR exhibit myocardial LGE nonischemic pattern LGE CMR OR subject high pretest probability cardiomyopathy persistent symptom comorbidities first degree relative patient know cardiomyopathy family history sudden cardiac death ( SCD ) know suspected myocardial infiltration due amyloidosis , iron accumulation , lipidstorage disease edema due active myocardial inflammation know ischemic heart disease ( IHD ) base least one following : significant document coronary artery disease ( CAD ) , previous coronary revascularization , previous history myocardial infarction , evidence ischemic typeLGE significant inducible ischemia CMR history renal disease current eGFR &lt; 30 mL/min/1.73m2 signifact structural valvular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>T1 mapping</keyword>
	<keyword>CMR</keyword>
	<keyword>Outcome</keyword>
	<keyword>multicenter</keyword>
</DOC>